Oxford Drug Design has started work on a new €3.4 Million Horizon 2020 Marie Curie European Training Network – CARTNET, “Combating Antimicrobial Resistance Training Network”.
CARTNET brings together 13 academic and industrial research groups from 8 countries and will contribute to delivering solutions to the challenges of bacterial infectious diseases that affect both humans and animals.
Oxford Drug Design will use its state-of-the-art drug discovery tools to optimize existing inhibitors of the novel class of antibacterial targets, histidine kinases, and to aid the discovery of new ones. The ultimate aim is to develop antibacterial compounds with a good resistance profile as candidate novel antibiotics.
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 765147.